Beutlich Pharmaceuticals

Beutlich Pharmaceuticals is a U.S. healthcare products company focused on pain management, dental products, and selected over-the-counter medical products. The company is best known for the HurriCaine family of 20% benzocaine topical anesthetics used by dental and medical professionals, as well as related oral-care and preventive-care products such as HurriView plaque-indicating swabs and HurriSeal dentin desensitizer. Its portfolio also includes CEO-TWO laxative suppositories and other commercially marketed products rather than a traditional clinical-development pipeline. Beutlich became part of Nuance Medical in 2023 and now operates within Nuance's pain management and dental portfolio, while the Beutlich name continues to appear on product labeling, support materials, and contact channels.